Dr.Vad
24.03.2007, 00:09
The mean incidence of infections per subject was significantly lower in the zinc compared with the placebo group after 1 year (0.29 vs 1.4; P < .01; effect size, 1.46).
There was a trend toward a lower incidence of the common cold in the zinc group.
17 subjects in the zinc group compared with 3 subjects in the placebo group had no evidence of infection during 1 year.
The total number of infections in the zinc group was 7 compared with 35 in the placebo group during 1 year.
Plasma zinc levels were significantly higher in the zinc group at 1 year compared with the placebo group.
Plasma molecular markers of oxidative stress showed greater decrease in the zinc compared with the placebo group.
The generation of inflammatory cytokines was significantly lower in the zinc than in the placebo group.
[Ссылки могут видеть только зарегистрированные и активированные пользователи]
There was a trend toward a lower incidence of the common cold in the zinc group.
17 subjects in the zinc group compared with 3 subjects in the placebo group had no evidence of infection during 1 year.
The total number of infections in the zinc group was 7 compared with 35 in the placebo group during 1 year.
Plasma zinc levels were significantly higher in the zinc group at 1 year compared with the placebo group.
Plasma molecular markers of oxidative stress showed greater decrease in the zinc compared with the placebo group.
The generation of inflammatory cytokines was significantly lower in the zinc than in the placebo group.
[Ссылки могут видеть только зарегистрированные и активированные пользователи]